Arrowhead’s 6th Annual Personalized & Precision Medicine Conference is coming to San Francisco, October 29-30, 2014

About the Conference

Arrowhead’s 6th Annual Personalized & Precision Medicine Conference is coming to San Francisco in October. The conference will be exploring the ways in which Personalized & Precision Medicine is reshaping healthcare. This conference brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic view of the personalized medicine landscape. As the field evolves, so has the Annual Personalized Medicine Conference. This year’s conference will continue to examine the components that are integral to driving personalized medicine into the future, including:

▶ Ethical/social/legal issues	▶ Transforming data into actionable guidance in the clinic
▶ Weighing clinical utility	▶ Personalized medicine at the bedside
▶ Payor evaluation of next gen sequencing	▶ Aligning labs, clinicians and payers
▶ Development of genomic medicine programs

Key Themes

Clinical Implementation of Personalized Medicine. Speakers and panelists will illustrate how physicians are incorporating genetic data into the treatment of various diseases and will discuss what the challenges are in bringing more genetically-guided therapy into the clinic.

Biomarkers & Genomics. Speakers and panelists will provide case studies exploring how diagnostics companies/developers of biomarkers and labs are working with drug developers to bring to market new companion diagnostics and targeted therapies to ensure greater efficacy and thus better patient outcomes.

Genomic Data: Infrastructure, Interpretation & Outcomes.Next generation, exome, and whole genome sequencing are accelerating the creation of even more data whose use is critical to the growth of personalized medicine. Speakers and panelists will explore clinical, ethical, technological and business strategy issues related to data collection, sharing and use in the context of the growth needs for personalized medicine.

New Stakeholders & Changing Relationships. Speakers and panelists will discuss the challenges that still exist in terms of reimbursement of molecular diagnostics and lab-developed tests which help guide personalized healthcare. Insurers and reimbursement experts will present their viewpoints and analysis of emerging policies regarding personalized medicine.

Questions Answered

Speakers and panelists will answer the following key questions:

Is personalized medicine changing clinical practice?
Can personalized medicine improve clinical outcomes?
How is comparative effectiveness and evidence research furthering the field of personalized medicine?
Will insurers fund the genomic revolution?
What types of validation requirements are payors looking for?
What are the newest developments in payors’ criteria for reimbursement?
What are the real-world challenges to successful adoption of molecular/companion diagnostics?
How is whole genome sequencing being integrated into clinical practice?
How is genomic information being stored, utilized and safeguarded in the era of personalized medicine?
What types of efforts are being made to influence adoption via physician education?

Key Features

PRESENTATIONS from Physicians, Researchers, Reimbursement Experts, Payers and Leaders from the Molecular Diagnostics, Biopharmaceutical and Genome Interpretation Industries
Extended Q&A SESSIONS with Speakers
PANEL DISCUSSIONS covering a variety of topics of interest to stakeholders in personalized medicine
Numerous NETWORKING OPPORTUNITIES aided by Arrowhead’s pre-conference online networking suite

SOURCE

http://www.personalizedmedicinepartnerships.com/

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com